Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesAcura Pharmaceuticals and King Pharmaceuticals Provide Update on ACUROX® NDA
King Pharmaceuticals, 09/04/09
Acura Pharmaceuticals, Inc. and King Pharmaceuticals, Inc. announced that they met with the U.S. Food and Drug Administration on September 2009 to discuss the FDA's Complete Response Letter regarding the New Drug Application for ACUROX Tablets CII. The FDA and the Companies agreed to take the NDA to an FDA Advisory Committee to consider the evidence to support the potential opioid abuse deterrent effects of ACUROX Tablets.
Today in Drug Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Mylan Receives Approval for Generic Version of Antiepileptic Keppra 1000 mg
Mylan, 12/15/09
FDA Approves Newly Revised Prescribing Information For Azilect Reducing Medication And Food Restrictions
Teva Pharmaceutical Industries, 12/15/09
FDA Advisory Committee Supports Use of Aztreonam for Inhalation Solution for Patients with Cystic Fibrosis
Gilead, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor